Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effects of Selective Serotonin Reuptake Inhibitors on Dna Damage in Patients With Depression Publisher Pubmed



Ahmadimanesh M1 ; Abbaszadegan MR2 ; Morshedi Rad D3 ; Moallem SA1, 4 ; Mohammadpour AH5, 6 ; Ghahremani MH7 ; Farid Hosseini F8 ; Behdani F8 ; Akhondpour Manteghi A8 ; Jowsey P9 ; Shabani Behbahani F1 ; Moallem SMH10 ; Etemad L6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmacodynamics and Toxicology, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  3. 3. Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  4. 4. Department of Pharmacology and Toxicology, Al Zahra University, Karbala, Iraq
  5. 5. Department of Clinical Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
  6. 6. Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
  7. 7. Department of Toxicology-Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  9. 9. National Institute for Health Research (NIHR), Health Protection Research Unit for Chemical and Radiation Threats and Hazards, Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom
  10. 10. School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Source: Journal of Psychopharmacology Published:2019


Abstract

Background: The relationship between depression and increased oxidative stress is well known. DNA damage by oxidation factors is an important cause of the aging process in psychiatric disorders. Aims: Owing to the scarcity of human studies and high inconsistencies in studies of the effects of antidepressants on DNA damage, the current study was undertaken to investigate the effects of depression and its treatment on DNA damage. Methods: In a 15-week open-label study of citalopram (n = 25) and sertraline (n = 20), levels of DNA damage were measured by comet assay, proinflammatory (Interlukin-6 (IL-6)) and oxidative DNA damage (8-hydroxy-2’-deoxyguanosine (8-OHdG)) markers by ELISA, and gene expression of base excision repair enzymes (8-oxoguanine glycosylase (OGG1) and poly (ADP)-ribose polymerase-1 (PARP1)) by quantitative real-time polymerase chain reaction in healthy control patients (n = 14), with depression at the baseline and the same patients after week 15. Results: DNA damage, 8-OHdG, IL-6 and expression of PARP1 were elevated in patients with depression compared with the healthy controls (p < 0.001). Selective serotonin reuptake inhibitor (SSRI) therapy could significantly reduce the depression score (p < 0.01), DNA damage (p < 0.001), as well as 8-OHdG and IL-6 (p < 0.0001). Nevertheless, the expression of PARP1 and OGG1 showed no significant changes after treatment. Conclusions: This is the first study on the effect of SSRIs on the DNA damage and some of the repair enzymes in depression. Based on the results, depression can cause increased DNA damage. This damage is followed by activation of compensatory mechanisms whereby the expression of DNA damage repair enzymes is elevated. Finally, the treatment of psychiatric disorder by antidepressants can lower the level of oxidative DNA damage. © The Author(s) 2019.